Introduction

  • D. K. C. Cooper
  • E. Kemp
  • K. Reemtsma
  • D. J. G. White

Abstract

In 1969 (when the terms heterograft and homograft were still being used to describe the xenograft and allograft, respectively), no less an authority than Sir Peter Medawar made the following prophetic remarks: “A new solution is therefore called for: the use of heterografts — that is to say, of grafts transplanted from lower animals into man. Of the use of heterografts I can say only this: that in the laboratory we are achieving greater success with grafts between species today than we achieved with grafts within 15 years ago. We shall solve the problem by using heterografts one day if we try hard enough, and maybe in less than 15 years.” [1].

Keywords

Hepatitis Expense Rapamycin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Medawar, P. Quoted by Reemtsma, K. Heterotransplantation. Transplant. Proc. 1, 251, 1969.Google Scholar
  2. 2.
    Calne, R.Y. Organ transplantation between widely disparate species. Transplant. Proc. 2, 550, 1970.PubMedGoogle Scholar
  3. 3.
    Alexandre, G.PJ., Squifflet, J.P., De Bruyere, M., Latinne, D., Reding, R., Gianello, P., Carlier, M., Pirson, Y. Present experience in a series of 26 ABO-incompatible living donor renal allografts. Transplant. Proc. 19,4538, 1987.PubMedGoogle Scholar
  4. 4.
    Palmer, A., Welsh, K., Gjorstrup, P., Taube, D., Bewick, M., Thick, M. Removal of anti- HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet. 1,10, 1989.PubMedCrossRefGoogle Scholar
  5. 5.
    Auchincloss, H. Jr. Xenogeneic transplantation. Transplantation. 46,1, 198.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • D. K. C. Cooper
  • E. Kemp
  • K. Reemtsma
  • D. J. G. White

There are no affiliations available

Personalised recommendations